Umlaut.Bio
Heidelberg
About Umlaut.Bio
Umlaut.Bio is a spinout of the European Molecule Biology Laboratory (EMBL), is pursuing tRNA targets for treatment of cancer and immunological diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.5M
- Funding stage: Seed
- Last round: Pre-Seed (Feb 2026)
- Website: umlaut.bio
Canonical: https://fsome.com/organization/umlaut-bio-2439034 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.